scholarly journals Phase I study of alpelisib (BYL719), an α-specific PI3K inhibitor, in Japanese patients with advanced solid tumors

2019 ◽  
Vol 110 (3) ◽  
pp. 1021-1031 ◽  
Author(s):  
Yuichi Ando ◽  
Satoru Iwasa ◽  
Shunji Takahashi ◽  
Hideo Saka ◽  
Tomoyuki Kakizume ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients ◽  
Pi3k Inhibitor ◽  
Advanced Solid Tumors

A phase I study of resminostat in Japanese patients with advanced solid tumors

2015 ◽  
Vol 75 (6) ◽  
pp. 1155-1161 ◽  
Author(s):  
Satoru Kitazono ◽  
Yutaka Fujiwara ◽  
Shinji Nakamichi ◽  
Hidenori Mizugaki ◽  
Hiroshi Nokihara ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients ◽  
Advanced Solid Tumors

scholarly journals A Phase I study of intravenous PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumors

2016 ◽  
Vol 79 (1) ◽  
pp. 89-98 ◽  
Author(s):  
Toshihiko Doi ◽  
Nozomu Fuse ◽  
Takayuki Yoshino ◽  
Takashi Kojima ◽  
Hideaki Bando ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients ◽  
Pi3k Inhibitor

Abstract A167: A phase I study of single-agent BEZ235 (SDS sachet), once- or twice-daily, in Japanese patients with advanced solid tumors.

2013 ◽  
Author(s):  
Koichiro Watanabe ◽  
Hironobu Minami ◽  
Satoshi Otsu ◽  
Yoshinori Hirashima ◽  
Ryotaro Morinaga ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Single Agent ◽  
Japanese Patients ◽  
Advanced Solid Tumors

scholarly journals Phase I study of single-agent ribociclib in Japanese patients with advanced solid tumors

2017 ◽  
Vol 109 (1) ◽  
pp. 193-198 ◽  
Author(s):  
Toshihiko Doi ◽  
Becker Hewes ◽  
Tomoyuki Kakizume ◽  
Takeshi Tajima ◽  
Norifumi Ishikawa ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Single Agent ◽  
Japanese Patients ◽  
Advanced Solid Tumors

First-in-human phase I study of the oral PI3K inhibitor BEZ235 in patients (pts) with advanced solid tumors.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 3005-3005 ◽  
Author(s):  
H. Burris ◽  
J. Rodon ◽  
S. Sharma ◽  
R. S. Herbst ◽  
J. Tabernero ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Pi3k Inhibitor ◽  
Advanced Solid Tumors

scholarly journals Phase I study of roniciclib (BAY1000394), an oral CDK inhibitor in Japanese patients with advanced solid tumors

2016 ◽  
Vol 27 ◽  
pp. vii87-vii88
Author(s):  
Takashi Seto ◽  
Kaname Nosaki ◽  
Gen Shinoda ◽  
Kensei Hashizume ◽  
Iku Yamaguchi ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients ◽  
Cdk Inhibitor ◽  
Advanced Solid Tumors

scholarly journals Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors

2019 ◽  
Vol 84 (2) ◽  
pp. 393-404 ◽  
Author(s):  
Toshihiko Doi ◽  
Yutaka Fujiwara ◽  
Nobuaki Matsubara ◽  
Junichi Tomomatsu ◽  
Satoru Iwasa ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Single Agent ◽  
Japanese Patients ◽  
Advanced Solid Tumors
Sign in / Sign up

Export Citation Format

Share Document